Response to: 'Tapering antirheumatic drugs in a resource-poor setting: real-world evidence' by Haroon et al. van Mulligen E, de Jong PHP. Ann Rheum Dis 2022;81:e209.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

van Mulligen E, de Jong PHP. Response to: 'Tapering antirheumatic drugs in a resource-poor setting: real-world evidence' by Haroon et al. Ann Rheum Dis 2022;81:e209.
PMID: 32816708